Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 78


Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

Carey LA, Berry DA, Cirrincione CT, Barry WT, Pitcher BN, Harris LN, Ollila DW, Krop IE, Henry NL, Weckstein DJ, Anders CK, Singh B, Hoadley KA, Iglesia M, Cheang MC, Perou CM, Winer EP, Hudis CA.

J Clin Oncol. 2015 Nov 2. pii: JCO.2015.62.1268. [Epub ahead of print]


Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers.

Varadan V, Kamalakaran S, Gilmore H, Banerjee N, Janevski A, Miskimen KL, Williams N, Basavanhalli A, Madabhushi A, Lezon-Geyda K, Bossuyt V, Lannin DR, Abu-Khalaf M, Sikov W, Dimitrova N, Harris LN.

Int J Cancer. 2015 Aug 18. doi: 10.1002/ijc.29808. [Epub ahead of print]


Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Van Poznak C, Harris LN, Somerfield MR.

J Oncol Pract. 2015 Nov;11(6):514-6. doi: 10.1200/JOP.2015.005215. Epub 2015 Jul 21. No abstract available.


Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Van Poznak C, Somerfield MR, Bast RC, Cristofanilli M, Goetz MP, Gonzalez-Angulo AM, Hicks DG, Hill EG, Liu MC, Lucas W, Mayer IA, Mennel RG, Symmans WF, Hayes DF, Harris LN.

J Clin Oncol. 2015 Aug 20;33(24):2695-704. doi: 10.1200/JCO.2015.61.1459. Epub 2015 Jul 20.


Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer.

Merry CR, McMahon S, Thompson CL, Miskimen KL, Harris LN, Khalil AM.

Breast Cancer Res Treat. 2015 Apr;150(2):321-34. doi: 10.1007/s10549-015-3327-1. Epub 2015 Mar 8.


Biologic, demographic, and social factors affecting triple negative breast cancer outcomes.

Turkman YE, Sakibia Opong A, Harris LN, Knobf MT.

Clin J Oncol Nurs. 2015 Feb;19(1):62-7. doi: 10.1188/15.CJON.62-67.


Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN.

Cancer. 2015 Jun 1;121(11):1817-26. doi: 10.1002/cncr.29254. Epub 2015 Feb 3.


Project connect online: user and visitor experiences of an Internet-based intervention for women with breast cancer.

Harris LN, Cleary EH, Stanton AL.

Psychooncology. 2015 Sep;24(9):1145-51. doi: 10.1002/pon.3734. Epub 2014 Dec 17.


Evolution and origin of sympatric shallow-water morphotypes of Lake Trout, Salvelinus namaycush, in Canada's Great Bear Lake.

Harris LN, Chavarie L, Bajno R, Howland KL, Wiley SH, Tonn WM, Taylor EB.

Heredity (Edinb). 2015 Jan;114(1):94-106. doi: 10.1038/hdy.2014.74. Epub 2014 Sep 10.


Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab.

Cheng H, Bai Y, Sikov W, Sinclair N, Bossuyt V, Abu-Khalaf MM, Harris LN, Rimm DL.

BMC Cancer. 2014 May 8;14:326. doi: 10.1186/1471-2407-14-326.


Error-related negativities during spelling judgments expose orthographic knowledge.

Harris LN, Perfetti CA, Rickles B.

Neuropsychologia. 2014 Feb;54:112-28. doi: 10.1016/j.neuropsychologia.2013.12.007. Epub 2013 Dec 31.


Genetic analysis of sympatric migratory ecotypes of Arctic charr Salvelinus alpinus: alternative mating tactics or reproductively isolated strategies?

Moore JS, Loewen TN, Harris LN, Tallman RF.

J Fish Biol. 2014 Jan;84(1):145-62. doi: 10.1111/jfb.12262.


The renaissance of endocrine therapy in breast cancer.

Williams N, Harris LN.

Curr Opin Obstet Gynecol. 2014 Feb;26(1):41-7. doi: 10.1097/GCO.0000000000000039. Review.


Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.

Lindner R, Sullivan C, Offor O, Lezon-Geyda K, Halligan K, Fischbach N, Shah M, Bossuyt V, Schulz V, Tuck DP, Harris LN.

PLoS One. 2013 Nov 18;8(11):e71915. doi: 10.1371/journal.pone.0071915. eCollection 2013.


Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

Dueck AC, Reinholz MM, Geiger XJ, Tenner K, Ballman K, Jenkins RB, Riehle D, Chen B, McCullough AE, Davidson NE, Martino S, Sledge GW, Kaufman PA, Kutteh LA, Gralow J, Harris LN, Ingle JN, Lingle WL, Perez EA.

Clin Cancer Res. 2013 Oct 15;19(20):5798-807. doi: 10.1158/1078-0432.CCR-13-0558. Epub 2013 Aug 21.


Early stage visual-orthographic processes predict long-term retention of word form and meaning: a visual encoding training study.

Cao F, Rickles B, Vu M, Zhu Z, Chan DH, Harris LN, Stafura J, Xu Y, Perfetti CA.

J Neurolinguistics. 2013 Jul 1;26(4):440-461.


Translating next generation sequencing to practice: opportunities and necessary steps.

Kamalakaran S, Varadan V, Janevski A, Banerjee N, Tuck D, McCombie WR, Dimitrova N, Harris LN.

Mol Oncol. 2013 Aug;7(4):743-55. doi: 10.1016/j.molonc.2013.04.008. Epub 2013 May 15. Review.


Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial.

Perez EA, Dueck AC, McCullough AE, Chen B, Geiger XJ, Jenkins RB, Lingle WL, Davidson NE, Martino S, Kaufman PA, Kutteh LA, Sledge GW, Harris LN, Gralow JR, Reinholz MM.

J Clin Oncol. 2013 Jun 10;31(17):2115-22. doi: 10.1200/JCO.2012.42.2642. Epub 2013 May 6.


HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade.

Kim YJ, Greer CB, Cecchini KR, Harris LN, Tuck DP, Kim TH.

Oncogene. 2013 Jun 6;32(23):2828-35. doi: 10.1038/onc.2013.32. Epub 2013 Feb 25.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk